annual EBITDA:
-$88.10M-$80.91M(-1126.11%)Summary
- As of today (September 6, 2025), ORKA annual EBITDA is -$88.10 million, with the most recent change of -$80.91 million (-1126.11%) on December 31, 2024.
- During the last 3 years, ORKA annual EBITDA has fallen by -$68.85 million (-357.78%).
- ORKA annual EBITDA is now -1960.24% below its all-time high of -$4.28 million, reached on December 1, 2012.
Performance
ORKA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$28.41M-$3.34M(-13.32%)Summary
- As of today (September 6, 2025), ORKA quarterly EBITDA is -$28.41 million, with the most recent change of -$3.34 million (-13.32%) on June 30, 2025.
- Over the past year, ORKA quarterly EBITDA has dropped by -$6.92 million (-32.18%).
- ORKA quarterly EBITDA is now -197.95% below its all-time high of $29.01 million, reached on June 1, 2007.
Performance
ORKA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$113.25M-$6.92M(-6.50%)Summary
- As of today (September 6, 2025), ORKA TTM EBITDA is -$113.25 million, with the most recent change of -$6.92 million (-6.50%) on June 30, 2025.
- Over the past year, ORKA TTM EBITDA has dropped by -$81.42 million (-255.80%).
- ORKA TTM EBITDA is now -7027.19% below its all-time high of -$1.59 million, reached on March 1, 2008.
Performance
ORKA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ORKA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1126.1% | -32.2% | -255.8% |
| 3 y3 years | -357.8% | -1083.8% | -608.3% |
| 5 y5 years | -1438.8% | -2112.6% | -1846.9% |
ORKA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1126.1% | at low | -1728.2% | +6.2% | -1518.1% | at low |
| 5 y | 5-year | -1438.8% | at low | -1728.2% | +6.2% | -1846.9% | at low |
| alltime | all time | -1960.2% | +35.9% | -197.9% | +35.9% | -7027.2% | at low |
ORKA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$28.41M(+13.3%) | -$113.25M(+6.5%) |
| Mar 2025 | - | -$25.07M(-17.3%) | -$106.33M(+20.7%) |
| Dec 2024 | -$88.10M(+1126.1%) | -$30.30M(+2.8%) | -$88.13M(+48.4%) |
| Sep 2024 | - | -$29.47M(+37.1%) | -$59.39M(+86.6%) |
| Jun 2024 | - | -$21.49M(+213.2%) | -$31.83M(+159.2%) |
| Mar 2024 | - | -$6.86M(+338.0%) | -$12.28M(+70.9%) |
| Dec 2023 | -$7.18M(-26.1%) | - | - |
| Dec 2023 | - | -$1.57M(-17.8%) | -$7.18M(+0.2%) |
| Sep 2023 | - | -$1.91M(-1.9%) | -$7.17M(+2.5%) |
| Jun 2023 | - | -$1.94M(+10.0%) | -$7.00M(-6.1%) |
| Mar 2023 | - | -$1.77M(+13.7%) | -$7.46M(-16.6%) |
| Dec 2022 | -$9.73M(-49.5%) | - | - |
| Dec 2022 | - | -$1.55M(-10.4%) | -$8.94M(-31.4%) |
| Sep 2022 | - | -$1.73M(-27.8%) | -$13.04M(-18.5%) |
| Jun 2022 | - | -$2.40M(-26.1%) | -$15.99M(-13.1%) |
| Mar 2022 | - | -$3.25M(-42.5%) | -$18.41M(-4.3%) |
| Dec 2021 | -$19.24M(+98.9%) | - | - |
| Dec 2021 | - | -$5.65M(+20.5%) | -$19.24M(+2.9%) |
| Sep 2021 | - | -$4.69M(-2.7%) | -$18.70M(+17.1%) |
| Jun 2021 | - | -$4.82M(+17.9%) | -$15.98M(+28.4%) |
| Mar 2021 | - | -$4.08M(-20.1%) | -$12.44M(+28.6%) |
| Dec 2020 | -$9.67M(+69.0%) | -$5.11M(+160.2%) | -$9.67M(+66.3%) |
| Sep 2020 | - | -$1.96M(+53.0%) | -$5.82M(+14.6%) |
| Jun 2020 | - | -$1.28M(-2.4%) | -$5.08M(-3.8%) |
| Mar 2020 | - | -$1.31M(+4.9%) | -$5.28M(-7.8%) |
| Dec 2019 | -$5.72M(-29.3%) | -$1.25M(+2.4%) | -$5.72M(-4.5%) |
| Sep 2019 | - | -$1.23M(-17.6%) | -$5.99M(-6.7%) |
| Jun 2019 | - | -$1.49M(-15.6%) | -$6.42M(-9.4%) |
| Mar 2019 | - | -$1.76M(+15.6%) | -$7.09M(-12.4%) |
| Dec 2018 | -$8.10M(-56.7%) | -$1.52M(-8.1%) | -$8.10M(-25.5%) |
| Sep 2018 | - | -$1.66M(-23.0%) | -$10.87M(-20.6%) |
| Jun 2018 | - | -$2.15M(-22.3%) | -$13.68M(-19.9%) |
| Mar 2018 | - | -$2.77M(-35.5%) | -$17.08M(-8.6%) |
| Dec 2017 | -$18.68M(+12.6%) | -$4.29M(-4.0%) | -$18.68M(+0.0%) |
| Sep 2017 | - | -$4.47M(-19.5%) | -$18.68M(-1.2%) |
| Jun 2017 | - | -$5.55M(+26.9%) | -$18.91M(+9.3%) |
| Mar 2017 | - | -$4.37M(+2.1%) | -$17.30M(+4.3%) |
| Dec 2016 | -$16.59M(+45.1%) | -$4.29M(-8.9%) | -$16.59M(+7.2%) |
| Sep 2016 | - | -$4.70M(+19.5%) | -$15.47M(+13.9%) |
| Jun 2016 | - | -$3.94M(+7.5%) | -$13.58M(+9.9%) |
| Mar 2016 | - | -$3.66M(+15.6%) | -$12.36M(+8.1%) |
| Dec 2015 | -$11.44M | -$3.17M(+12.7%) | -$11.44M(+5.2%) |
| Sep 2015 | - | -$2.81M(+3.6%) | -$10.87M(+5.1%) |
| Jun 2015 | - | -$2.71M(-0.9%) | -$10.34M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$2.74M(+5.1%) | -$10.03M(+3.6%) |
| Dec 2014 | -$9.68M(+40.0%) | -$2.61M(+14.3%) | -$9.68M(-3.4%) |
| Sep 2014 | - | -$2.28M(-5.1%) | -$10.02M(+5.9%) |
| Jun 2014 | - | -$2.40M(+0.7%) | -$9.46M(+14.7%) |
| Mar 2014 | - | -$2.39M(-18.9%) | -$8.24M(+19.2%) |
| Dec 2013 | -$6.91M(+61.7%) | -$2.94M(+71.2%) | -$6.91M(+44.1%) |
| Sep 2013 | - | -$1.72M(+44.7%) | -$4.80M(+20.1%) |
| Jun 2013 | - | -$1.19M(+12.2%) | -$4.00M(+1.4%) |
| Mar 2013 | - | -$1.06M(+27.7%) | -$3.94M(-7.8%) |
| Dec 2012 | -$4.28M(-36.7%) | -$830.00K(-9.6%) | -$4.28M(-14.4%) |
| Sep 2012 | - | -$918.00K(-19.1%) | -$5.00M(-10.4%) |
| Jun 2012 | - | -$1.14M(-18.5%) | -$5.58M(-7.5%) |
| Mar 2012 | - | -$1.39M(-10.2%) | -$6.03M(-10.8%) |
| Dec 2011 | -$6.76M(-23.5%) | -$1.55M(+3.5%) | -$6.76M(-9.6%) |
| Sep 2011 | - | -$1.50M(-5.8%) | -$7.48M(-6.5%) |
| Jun 2011 | - | -$1.59M(-25.0%) | -$8.00M(-6.9%) |
| Mar 2011 | - | -$2.12M(-6.5%) | -$8.60M(-2.7%) |
| Dec 2010 | -$8.84M(-60.5%) | -$2.27M(+12.2%) | -$8.84M(-1.0%) |
| Sep 2010 | - | -$2.02M(-7.5%) | -$8.93M(-9.9%) |
| Jun 2010 | - | -$2.19M(-7.5%) | -$9.91M(-33.7%) |
| Mar 2010 | - | -$2.36M(+0.1%) | -$14.95M(-33.2%) |
| Dec 2009 | -$22.39M(+16.2%) | -$2.36M(-21.5%) | -$22.39M(-10.6%) |
| Sep 2009 | - | -$3.00M(-58.5%) | -$25.04M(-11.8%) |
| Jun 2009 | - | -$7.23M(-26.2%) | -$28.38M(+13.1%) |
| Mar 2009 | - | -$9.80M(+95.8%) | -$25.10M(+30.2%) |
| Dec 2008 | -$19.27M(+35.6%) | -$5.00M(-21.1%) | -$19.27M(-31.8%) |
| Sep 2008 | - | -$6.34M(+60.5%) | -$28.24M(-18.2%) |
| Jun 2008 | - | -$3.95M(-0.5%) | -$34.55M(+2074.1%) |
| Mar 2008 | - | -$3.97M(-71.6%) | -$1.59M(-88.8%) |
| Dec 2007 | -$14.21M(-89.7%) | -$13.98M(+10.5%) | -$14.21M(-68.1%) |
| Sep 2007 | - | -$12.65M(-143.6%) | -$44.59M(-25.9%) |
| Jun 2007 | - | $29.01M(-274.8%) | -$60.16M(-45.0%) |
| Mar 2007 | - | -$16.59M(-62.6%) | -$109.33M(-3.4%) |
| Dec 2006 | -$137.39M(+95.2%) | -$44.35M(+57.2%) | -$113.21M(+26.5%) |
| Sep 2006 | - | -$28.22M(+39.9%) | -$89.49M(+46.1%) |
| Jun 2006 | - | -$20.17M(-1.5%) | -$61.27M(+49.1%) |
| Mar 2006 | - | -$20.47M(-0.8%) | -$41.10M(+99.2%) |
| Dec 2005 | -$70.37M(+58.6%) | -$20.63M(+370.1%) | -$20.63M(+370.1%) |
| Dec 2004 | -$44.36M(+4.4%) | - | - |
| Dec 2003 | -$42.49M(+19.3%) | - | - |
| Dec 2002 | -$35.62M(+21.9%) | - | - |
| Dec 2001 | -$29.21M(+48.8%) | - | - |
| Dec 2000 | -$19.63M(+15.6%) | - | - |
| Dec 1999 | -$16.98M(-2.5%) | -$4.39M | -$4.39M |
| Dec 1998 | -$17.42M | - | - |
FAQ
- What is Oruka Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Oruka Therapeutics, Inc.?
- What is Oruka Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Oruka Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Oruka Therapeutics, Inc.?
- What is Oruka Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Oruka Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Oruka Therapeutics, Inc.?
- What is Oruka Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Oruka Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of ORKA is -$88.10M
What is the all time high annual EBITDA for Oruka Therapeutics, Inc.?
Oruka Therapeutics, Inc. all-time high annual EBITDA is -$4.28M
What is Oruka Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ORKA annual EBITDA has changed by -$80.91M (-1126.11%)
What is Oruka Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ORKA is -$28.41M
What is the all time high quarterly EBITDA for Oruka Therapeutics, Inc.?
Oruka Therapeutics, Inc. all-time high quarterly EBITDA is $29.01M
What is Oruka Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ORKA quarterly EBITDA has changed by -$6.92M (-32.18%)
What is Oruka Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ORKA is -$113.25M
What is the all time high TTM EBITDA for Oruka Therapeutics, Inc.?
Oruka Therapeutics, Inc. all-time high TTM EBITDA is -$1.59M
What is Oruka Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ORKA TTM EBITDA has changed by -$81.42M (-255.80%)